Supplementation with selenium glycinate may increase the activities of related plasma enzymes, and reduce the levels of an important marker for the risk of prostate cancer, according to a new study that contradicts current thinking.
Supplementation with selenium glycinate may increase the activities of related plasma enzymes, and reduce the levels of an important marker for the risk of prostate cancer, according to a new study that contradicts current thinking.